Written and maintained by CASRAI Editorial Board
Last updated
Short answer
Pharmaceutical returns are drugs sent back up the supply chain instead of being dispensed or used. Where a returned product goes depends on its path: product that may be resold, nonsaleable product, or a controlled substance. Controlled substances have their own US rules, including DEA-registered reverse distributors, who must destroy controlled substances received for destruction within 30 calendar days. This is general regulatory information, not legal or medical advice.
Definition and scope
In this guide, a pharmaceutical return means a prescription drug product that a buyer (a pharmacy, clinic or other dispenser) sends back to a wholesaler, manufacturer or reverse distributor. The page covers US federal rules only. State licensing and state pharmacy rules also apply and are not covered here. It does not cover patient take-back programs, medical devices or laboratory consumables. For the licensing of the middleman in most of these flows, see pharmaceutical wholesalers.
How returns move: the reverse distribution step
The two federal sources below describe returns from different angles. The Drug Supply Chain Security Act (DSCSA), codified at 21 U.S.C. 360eee-1, governs product tracing, including what a distributor must check when a product comes back. The DEA rules at 21 CFR part 1317 govern what happens to controlled substances. For the trading-partner and tracing duties in general, see DSCSA compliance requirements for distributors.
A reverse distributor is the business that takes product back from the buyer. Under 21 CFR 1317.15(a), anyone who reverse distributes a controlled substance must be registered with the DEA as a reverse distributor, unless exempted by law or otherwise authorized.
Saleable, nonsaleable and controlled: three pathways compared
| Pathway | What the cited text says | Source |
|---|---|---|
| Product a distributor intends to resell | Before further distribution, the wholesale distributor must verify the product identifier, including the standardized numerical identifier, for each sealed homogeneous case or, if not in a sealed case, on each package. | 21 U.S.C. 360eee-1(c)(4)(D) |
| Nonsaleable product | A wholesale distributor may return nonsaleable product to the manufacturer or repackager, to the wholesale distributor from whom it was purchased, or to a person acting on their behalf (including a returns processor), without providing the transaction information that normally travels with product. | 21 U.S.C. 360eee-1(c)(1)(B)(ii) |
| Controlled substances, practitioner inventory | A registered practitioner may promptly destroy the substance on site, promptly deliver it to a reverse distributor’s registered location, or, for return or recall, send it to the registered person it was obtained from, the registered manufacturer or another registrant the manufacturer authorizes to accept returns. | 21 CFR 1317.05(a) |
| Controlled substances, at the reverse distributor | Store securely until timely destruction or prompt return to the manufacturer (or an authorized registrant), or destroy; destruction of material received for destruction is due no later than 30 calendar days after receipt. | 21 CFR 1317.15(c), (d) |
How a controlled-substance delivery is handled
Under 21 CFR 1317.15(b), a reverse distributor acquires controlled substances either by picking them up at the registrant’s registered location or authorized collection site, or by receiving them from a common or contract carrier or directly from a non-practitioner registrant. Delivery may only be made at the reverse distributor’s registered location, cannot be re-routed once en route, and must be personally received by an employee of the reverse distributor at that location.
What a buyer should confirm before sending product back
This checklist is derived directly from the provisions above. It is not a complete compliance program.
- Registration: for controlled substances, that the recipient is a DEA-registered reverse distributor or another registrant allowed to receive returns under 21 CFR 1317.05 and 1317.15.
- Delivery point: that deliveries go to the recipient’s registered location, since the rule does not allow delivery elsewhere or re-routing.
- Destruction timing: that the reverse distributor’s process meets the 30-calendar-day destruction limit for material received for destruction.
- Product identifier: for product a distributor intends to resell, that the distributor verifies the product identifier on return.
- Supplier terms: what the supplier’s own return policy allows. Reading a vendor’s return and restocking policy explains how those terms are usually structured.
Common misunderstandings
“A reverse distributor is just another carrier.”
For controlled substances it is a separately registered business with its own acquisition and destruction obligations under 21 CFR 1317.15.
“Anything unsold can be returned for credit.”
The federal texts above set conditions on who may receive, verify and destroy returned product. They do not promise credit. Whether a credit is issued is a matter of the supplier’s contract and policy.
“Expired or unwanted stock can be donated instead.”
Donation follows its own acceptance rules; see donating unused medical supplies. Near-dated stock that is still in date is a separate topic, covered in short-dated inventory.
FAQ
What is a reverse distributor?
A business that takes product back from a registrant. For controlled substances, 21 CFR 1317.15 requires it to hold a DEA registration as a reverse distributor.
How long does a reverse distributor have to destroy controlled substances?
No later than 30 calendar days after receipt, for material received for the purpose of destruction (21 CFR 1317.15(d)).
Can a practitioner destroy controlled substances on site?
21 CFR 1317.05(a) lists prompt on-site destruction under subpart C as one of the permitted options, alongside delivery to a reverse distributor and return to the supplier or manufacturer.
Must a wholesale distributor check returned product before reselling it?
Yes. 21 U.S.C. 360eee-1(c)(4)(D) requires verification of the product identifier before further distribution of returned product the distributor intends to resell.
Sources
- 21 CFR 1317.15, Reverse distributor registration requirements and authorized activities. https://www.law.cornell.edu/cfr/text/21/1317.15 (checked 2026-11-01).
- 21 CFR 1317.05, Registrant disposal. https://www.law.cornell.edu/cfr/text/21/1317.05 (checked 2026-11-01).
- 21 U.S.C. 360eee-1, Federal Food, Drug, and Cosmetic Act section 582. https://www.law.cornell.edu/uscode/text/21/360eee-1 (checked 2026-11-01).
- FDA, Drug Supply Chain Security Act (DSCSA). https://www.fda.gov/drugs/drug-supply-chain-integrity/drug-supply-chain-security-act-dscsa (checked 2026-11-01).
